BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22913794)

  • 1. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study.
    Schultheiß C; Saugel B; Phillip V; Thies P; Noe S; Mayr U; Haller B; Einwächter H; Schmid RM; Huber W
    Crit Care; 2012 Aug; 16(4):R162. PubMed ID: 22913794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained low-efficiency dialysis with regional citrate anticoagulation in medical intensive care unit patients with liver failure: A prospective study.
    Lahmer T; Messer M; Rasch S; Beitz A; Schnappauf C; Schmid RM; Huber W
    J Crit Care; 2015 Oct; 30(5):1096-100. PubMed ID: 26254678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study.
    Slowinski T; Morgera S; Joannidis M; Henneberg T; Stocker R; Helset E; Andersson K; Wehner M; Kozik-Jaromin J; Brett S; Hasslacher J; Stover JF; Peters H; Neumayer HH; Kindgen-Milles D
    Crit Care; 2015 Sep; 19():349. PubMed ID: 26415638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).
    Mitchell A; Daul AE; Beiderlinden M; Schäfers RF; Heemann U; Kribben A; Peters J; Philipp T; Wenzel RR
    Clin Nephrol; 2003 Feb; 59(2):106-14. PubMed ID: 12608553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation.
    Meier-Kriesche HU; Gitomer J; Finkel K; DuBose T
    Crit Care Med; 2001 Apr; 29(4):748-52. PubMed ID: 11373461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional citrate anticoagulation in patients with liver failure--time for a rethink?
    Patel S; Wendon J
    Crit Care; 2012 Sep; 16(5):153. PubMed ID: 22985662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrolyte monitoring during regional citrate anticoagulation in continuous renal replacement therapy.
    Warnar C; Faber E; Katinakis PA; Schermer T; Spronk PE
    J Clin Monit Comput; 2022 Jun; 36(3):871-877. PubMed ID: 33991270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients.
    Link A; Klingele M; Speer T; Rbah R; Pöss J; Lerner-Gräber A; Fliser D; Böhm M
    Crit Care; 2012 May; 16(3):R97. PubMed ID: 22643456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis.
    Zhang W; Bai M; Yu Y; Li L; Zhao L; Sun S; Chen X
    Crit Care; 2019 Jan; 23(1):22. PubMed ID: 30678706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction.
    Klingele M; Stadler T; Fliser D; Speer T; Groesdonk HV; Raddatz A
    Crit Care; 2017 Nov; 21(1):294. PubMed ID: 29187232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of regional citrate anticoagulation for continuous venovenous hemodialysis in critically ill cancer patients with acute kidney injury.
    Costa E Silva VT; Caires RA; Bezerra JS; Costalonga EC; Oliveira APL; Oliveira Coelho F; Fukushima JT; Soares CM; Oikawa L; Hajjar LA; Burdmann EA
    J Crit Care; 2018 Oct; 47():302-309. PubMed ID: 29859647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous hemodialysis with citrate anticoagulation and standard dialysate for managing acute kidney injury in patients with moderate to severe hyponatremia-A retrospective study.
    Hellman T; Uusalo P; Järvisalo MJ
    Acta Anaesthesiol Scand; 2021 Jul; 65(6):778-784. PubMed ID: 33595109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Continuous haemodialysis with citrate anticoagulation in patients with liver failure: three cases].
    Devauchelle P; Page M; Brun P; Ber CE; Crozon J; Baillon JJ; Allaouchiche B; Rimmelé T
    Ann Fr Anesth Reanim; 2012 Jun; 31(6):543-6. PubMed ID: 22465645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation.
    Meier-Kriesche HU; Finkel KW; Gitomer JJ; DuBose TD
    Am J Kidney Dis; 1999 Apr; 33(4):e8. PubMed ID: 10196039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperlactatemia Predicts Citrate Intolerance With Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy.
    Tan JN; Haroon SWP; Mukhopadhyay A; Lau T; Murali TM; Phua J; Tan ZY; Lee N; Chua HR
    J Intensive Care Med; 2019 May; 34(5):418-425. PubMed ID: 28372501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional citrate anticoagulation for continuous renal replacement therapy in the perioperative care of liver transplant recipients: a single center experience.
    Sponholz C; Settmacher U; Bauer M; Kortgen A
    Ther Apher Dial; 2015 Feb; 19(1):8-15. PubMed ID: 25196675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment dose and the elimination rates of electrolytes, vitamins, and trace elements during continuous veno-venous hemodialysis (CVVHD).
    Datzmann T; Träger K; Schröppel B; Reinelt H; von Freyberg P
    Int Urol Nephrol; 2018 Jun; 50(6):1143-1149. PubMed ID: 29611144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation in Children with Liver Dysfunction/Failure.
    Botan E; Durak A; Gün E; Gurbanov A; Balaban B; Kahveci F; Özen H; Uçmak H; Aycan F; Kendirli T
    J Trop Pediatr; 2022 Jun; 68(4):. PubMed ID: 35737953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation.
    Khadzhynov D; Schelter C; Lieker I; Mika A; Staeck O; Neumayer HH; Peters H; Slowinski T
    J Crit Care; 2014 Apr; 29(2):265-71. PubMed ID: 24360392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.